Fulgent Genetics, Inc.FLGTNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank3
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P3
Near historical low
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-1743.72%
Q3 2025113.67%
Q2 2025-304.38%
Q1 2025-143.07%
Q4 2024160.61%
Q3 2024-304.73%
Q2 2024-369.75%
Q1 2024-72.86%
Q4 2023122.44%
Q3 2023320.90%
Q2 202375.79%
Q1 2023-134.90%
Q4 202285.68%
Q3 202294.98%
Q2 2022-95.70%
Q1 2022157.41%
Q4 2021-52.21%
Q3 2021103.33%
Q2 2021-66.99%
Q1 2021100.69%
Q4 202015570.87%
Q3 202085.19%
Q2 2020-945.61%
Q1 2020179.83%
Q4 2019-118.72%
Q3 20192067.61%
Q2 2019-80.89%
Q1 201940.61%
Q4 2018156.86%
Q3 2018-91.04%
Q2 201874.95%
Q1 2018-1.05%
Q4 2017-8.37%
Q3 2017-3445.16%
Q2 2017-110.05%
Q1 2017-26.98%
Q4 2016141.87%
Q3 2016-284.80%
Q2 201656.45%
Q1 2016191.84%